RVPH vs. IESC

In the year-to-date period, RVPH achieves a -73.98% return, which is significantly lower than IESC's 168.24% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and IES Holdings, Inc. (IESC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RVPH Sharpe Ratio is -0.50, which is lower than the IESC Sharpe Ratio of 2.61. The chart below compares the historical Sharpe Ratios of RVPH and IESC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither RVPH nor IESC has paid dividends to shareholders.

The maximum RVPH drawdown since its inception was -94.95%, roughly equal to the maximum IESC drawdown of -99.54%. Use the drawdown chart below to compare losses from any high point for RVPH and IESC. For additional features, visit the drawdowns tool.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a higher volatility of 68.35% compared to IES Holdings, Inc. (IESC) at 19.27%. This indicates that RVPH's price experiences larger fluctuations and is considered to be riskier than IESC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Reviva Pharmaceuticals Holdings, Inc. and IES Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.